Acute Heart Failure Diuretic Escalation

Use IV loop diuretic therapy for acute heart failure with clinically evident congestion requiring decongestion. For patients not taking a loop diuretic, an initial furosemide dose of 20–40 mg IV is guideline-based. For patients on chronic loop therapy, give at least an IV dose equivalent to the oral home dose; position papers support an initial dose of approximately one to two times the oral home dose. WileyWileyRationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study - Dauw - 2021 - ESC Heart Failure - Wiley Online Library

If congestion is substantial or response to the home-equivalent dose is inadequate, a higher IV loop strategy is reasonable. In DOSE, a high-dose strategy of 2.5 times the oral home dose did not improve the 72-hour global symptom assessment versus a home-dose-equivalent strategy, but it produced greater dyspnea relief, weight loss, and net fluid loss. Wiley+1WileyRationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study - Dauw - 2021 - ESC Heart Failure - Wiley Online LibraryPubMedDiuretic Treatment in Heart Failure: A Practical Guide for Clinicians

Administer intermittent IV doses initially and judge effectiveness by early natriuresis or urine output, not by symptom trajectory alone. When a dose achieves the response target, continue that dose every 6–12 hours while congestion persists. Continuous furosemide infusion is an option in refractory cases, but it should not substitute for prompt reassessment after an ineffective bolus. ccjmccjm[PDF] How do we maximize diuresis in acute decompensated heart failure?

Obtain a spot urine sodium concentration 1–2 hours after the initial IV loop dose when catheterized or reliably collected urine is available. A value below 50–70 mmol/L at 2 hours indicates inadequate natriuresis and should trigger dose escalation. A spot sample has shown strong correlation with total sodium excretion and urine output from a 6-hour collection. PubMed+2PubMedKidney Disease and Heart Failure: Recent Advances and Current ChallengesPubMedFrom Hospital to Homeccjm[PDF] How do we maximize diuresis in acute decompensated heart failure?

If spot urine sodium is impractical, use hourly urine output. A target above 150 mL/hour at 2 hours supports adequate response; output below this threshold should prompt doubling of the prior IV loop dose, followed by repeat assessment 2 hours later. ccjmccjm[PDF] How do we maximize diuresis in acute decompensated heart failure?

European guidance also recognizes a 6-hour urine-output assessment after IV loop administration. Structured urine sodium-guided approaches increase diuretic intensification and natriuresis, but the role of serial urine sodium testing in improving definitive clinical outcomes remains under evaluation. ScienceDirect+2ScienceDirectRationale and Design of the DECONGEST (Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment) Study - ScienceDirectScienceDirectDiuretic resistance measured by sodium excretion and urine output in acute heart failure: The DIURESIS-AHF study - ScienceDirectPubMedFrom Hospital to Home

When the initial IV loop dose fails to achieve urine sodium above 50–70 mEq/L or urine output above 150 mL/hour at 2 hours, double the prior dose and repeat the same response measurement 2 hours later. Continue this loop-dose escalation until the response target is achieved or the maximum protocol dose is reached. ccjmccjm[PDF] How do we maximize diuresis in acute decompensated heart failure?

Once a response is established, maintain the effective dose every 6–12 hours rather than reverting to the ineffective starting dose. In a practical stepped strategy, persistent congestion with urine output below 3–4 L over 24 hours despite high-dose or maximized loop therapy is a trigger to add another diuretic mechanism. PubMedPubMedDiuretic Treatment in Heart Failure: A Practical Guide for Clinicians

Use the lowest loop dose that produces meaningful decongestion once euvolemia is approaching, because loop treatment requires an ongoing balance between decongestion and renal dysfunction, electrolyte disturbance, and neurohormonal activation. Nature+2NatureLoop Diuretic Applications in Heart Failure Management | Cardiology | Cardiovascular Medicine and Haematology | Health sciences | Topics | Nature IndexWileyRationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study - Dauw - 2021 - ESC Heart Failure - Wiley Online LibraryPubMedDiuretic Treatment in Heart Failure: A Practical Guide for Clinicians

For resistant edema that does not respond to higher loop-diuretic doses, add a thiazide-type diuretic to block distal tubular sodium reabsorption. European guidance gives loop-thiazide combination therapy a class IIa, level B recommendation in this situation. In CLOROTIC, oral hydrochlorothiazide added to IV furosemide improved diuretic response and produced greater 72-hour weight loss than placebo. Wiley+1WileyCombining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: A post‐hoc analysis of the CLOROTIC trial - Trullàs - 2023 - European Journal of Heart Failure - Wiley Online LibraryPubMedKidney Disease and Heart Failure: Recent Advances and Current Challenges

Use thiazide augmentation with active electrolyte and renal surveillance. Across CLOROTIC analyses, combination treatment increased fluid loss but was associated with more renal-function and electrolyte disturbances; meta-analytic evidence also associates loop-thiazide therapy with worsening renal function and hypokalemia. jacc+1jaccSimplifying Treatment of Congestion: Diuretic Response With Sequential Nephron Blockade Is Independent of Ejection FractionESCESC 365 - Diuretic strategies in acute heart failure: a systematic review and network meta-analysis of randomized clinical trials

Do not exclude thiazide augmentation solely because eGFR is below 30 mL/min/1.73 m². The historical assumption of absent efficacy at this threshold has been challenged, and CLOROTIC found no significant interaction between eGFR subgroup and hydrochlorothiazide effects on diuretic response or safety endpoints. WileyWileyCombining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: A post‐hoc analysis of the CLOROTIC trial - Trullàs - 2023 - European Journal of Heart Failure - Wiley Online Library

Consider ultrafiltration only when adequate loop dosing and adjunctive pharmacologic strategies fail to achieve decongestion. In CARRESS-HF, a stepped pharmacologic algorithm was superior to ultrafiltration for preservation of renal function at 96 hours, with similar weight loss. PubMed+1PubMedDiuretic Treatment in Heart Failure: A Practical Guide for CliniciansPubMedSystematic Review on the Management of Diuretic Resistance in Acute Heart Failure across the Spectrum of Kidney Disease

In the CARRESS-HF comparison, serum creatinine increased by 0.23 mg/dL with ultrafiltration versus decreased by 0.04 mg/dL with stepped pharmacologic therapy at 96 hours; weight loss was similar, and serious adverse events through 60 days were more frequent with ultrafiltration (72% versus 57%). These findings favor continued pharmacologic escalation in patients who remain candidates for it. PubMedPubMedFrom Hospital to Home

Before discharge, confirm that congestion has been meaningfully resolved rather than accepting symptomatic improvement alone. Residual congestion at discharge is associated with higher heart-failure readmission and mortality, making completion of decongestion a central inpatient target. jacc+1jaccSimplifying Treatment of Congestion: Diuretic Response With Sequential Nephron Blockade Is Independent of Ejection FractionPubMedFrom Hospital to Home